Search research articles
Contact Us
Filters
Showing results (111-120 of 137) with videos related to
Page
of 14
Sort By:
Pharmacology Research & Perspectives
|
March 26, 2019
Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease
Fernando L Pagan, Michaeline L Hebron, Barbara Wilmarth, et al.
JAMA Neurology
|
December 17, 2019
Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial
Fernando L Pagan, Michaeline L Hebron, Barbara Wilmarth, et al.
Annals of Neurology
|
May 30, 2020
Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's Disease
Raymond S Turner, Michaeline L Hebron, Abigail Lawler, et al.
The American Journal of Pathology
|
June 10, 2026
APOE4 Increases Systemic Inflammation and Alters Metabolic and Neuroprotective Pathways following Multi-Agent Chemotherapy in Older Human APOE Knock-In Mice
Aisha Naeem, Michaela McCormack, Ryan Lein, et al.
Cancer
|
March 23, 2023
The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real-world, multicenter, retrospective study
Shaked Lev-Ari, Michael Serzan, Tianmin Wu, et al.
Breast Cancer Research and Treatment
|
November 24, 2021
Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis
Brent J Small, Marie Lange, Wanting Zhai, et al.
JNCI Cancer Spectrum
|
March 22, 2021
Protective Effects of <i>APOE</i> ε2 Genotype on Cognition in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study
Kathleen Van Dyk, Xingtao Zhou, Brent J Small, et al.
JNCI Cancer Spectrum
|
March 31, 2024
Prediction of cognitive decline in older breast cancer survivors: the Thinking and Living with Cancer study
Arthur Patrick McDeed, Kathleen Van Dyk, Xingtao Zhou, et al.
Cancers
|
June 27, 2024
Clinical Outcomes of Immune Checkpoint Inhibitors in Unique Cohorts Underrepresented in Clinical Trials
Neil J Shah, Alexandra Della Pia, Tianmin Wu, et al.
Journal of Geriatric Oncology
|
August 27, 2022
Associating persistent self-reported cognitive decline with neurocognitive decline in older breast cancer survivors using machine learning: The Thinking and Living with Cancer study
Kathleen Van Dyk, Jaeil Ahn, Xingtao Zhou, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 137) with videos related to
Sort By:
Page
of 14
Pharmacology Research & Perspectives
|
March 26, 2019
Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease
Fernando L Pagan, Michaeline L Hebron, Barbara Wilmarth, et al.
JAMA Neurology
|
December 17, 2019
Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial
Fernando L Pagan, Michaeline L Hebron, Barbara Wilmarth, et al.
Annals of Neurology
|
May 30, 2020
Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's Disease
Raymond S Turner, Michaeline L Hebron, Abigail Lawler, et al.
The American Journal of Pathology
|
June 10, 2026
APOE4 Increases Systemic Inflammation and Alters Metabolic and Neuroprotective Pathways following Multi-Agent Chemotherapy in Older Human APOE Knock-In Mice
Aisha Naeem, Michaela McCormack, Ryan Lein, et al.
Cancer
|
March 23, 2023
The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real-world, multicenter, retrospective study
Shaked Lev-Ari, Michael Serzan, Tianmin Wu, et al.
Breast Cancer Research and Treatment
|
November 24, 2021
Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis
Brent J Small, Marie Lange, Wanting Zhai, et al.
JNCI Cancer Spectrum
|
March 22, 2021
Protective Effects of <i>APOE</i> ε2 Genotype on Cognition in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study
Kathleen Van Dyk, Xingtao Zhou, Brent J Small, et al.
JNCI Cancer Spectrum
|
March 31, 2024
Prediction of cognitive decline in older breast cancer survivors: the Thinking and Living with Cancer study
Arthur Patrick McDeed, Kathleen Van Dyk, Xingtao Zhou, et al.
Cancers
|
June 27, 2024
Clinical Outcomes of Immune Checkpoint Inhibitors in Unique Cohorts Underrepresented in Clinical Trials
Neil J Shah, Alexandra Della Pia, Tianmin Wu, et al.
Journal of Geriatric Oncology
|
August 27, 2022
Associating persistent self-reported cognitive decline with neurocognitive decline in older breast cancer survivors using machine learning: The Thinking and Living with Cancer study
Kathleen Van Dyk, Jaeil Ahn, Xingtao Zhou, et al.
Page
of 14